Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2009
03/18/2009CN100469793C Anti-osteopontin antibody and use thereof
03/18/2009CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides
03/18/2009CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
03/18/2009CN100469778C Novel fused imidazole derivative
03/18/2009CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors
03/18/2009CN100469390C Use of bromelain in preparing medicament for increasing individual IL-8 content
03/18/2009CN100469379C Medical liquor for curing rheumatic numbness
03/18/2009CN100469368C Use of adatanserin for treating neurogenerative disorders
03/18/2009CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/18/2009CN100469357C Tablet for treating difficult menstruation and its preparation
03/18/2009CN100469355C Nutritional supplements and methods of using same
03/17/2009US7504537 osteoarthritis or rheumatoid arthritis
03/17/2009US7504482 Recombinant soluble Fc receptors
03/17/2009US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
03/17/2009US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation
03/17/2009US7504237 Polynucleotides encoding interferon gamma polypeptides
03/17/2009US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases
03/17/2009US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis
03/17/2009CA2502731C Sustained release composition for oral administration of drugs
03/17/2009CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives
03/17/2009CA2359116C Substituted porphyrins
03/17/2009CA2330025C Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/17/2009CA2328234C Compounds that inhibit the binding of integrins to their receptors
03/17/2009CA2194064C Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
03/12/2009WO2009031878A1 Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency
03/12/2009WO2009031877A1 Pharmaceutical composition combining acemetacin, methocarbamol and diacerein, which can be used in the treatment of rheumatoid arthritis and related diseases
03/12/2009WO2009031826A1 Process for preparing vitis vinifera pip extract and pharmaceutical composition for preventing or treating rheumatoid arthritis comprising the same
03/12/2009WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN
03/12/2009WO2009031627A1 Para-terphenyl compound or pharmacologically acceptable salt thereof, method for production of the same, and use of the same
03/12/2009WO2009031606A1 Therapeutic and prophylactic agents for arthritis
03/12/2009WO2009031318A1 Preparation for external application comprising analgesic/anti-inflammatory agent
03/12/2009WO2009030492A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion
03/12/2009WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
03/12/2009WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity
03/12/2009WO2009007680A3 Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders
03/12/2009WO2009007679A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
03/12/2009WO2009007675A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
03/12/2009WO2008149244A3 Compositions and methods comprising analogues of radicicol a
03/12/2009WO2008109498A3 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof
03/12/2009WO2006122806A3 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors
03/12/2009US20090069565 New indole derivatives as factor xa inhibitors
03/12/2009US20090069553 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
03/12/2009US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells
03/12/2009US20090069426 Methods For Reducing The Amount Of A Proinflammatory Substance In Animal Tissue Or Body Fluid
03/12/2009US20090069383 Thrombin Receptor Antagonists
03/12/2009US20090069373 Quinoline Acids
03/12/2009US20090069347 2-phenoxy pyrimidinone analogues
03/12/2009US20090069338 Method for predicting skin sensitizing activity of compounds
03/12/2009US20090069332 Novel pyridazine derivatives and medicines containing the same as effective ingredients
03/12/2009US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity
03/12/2009US20090069320 Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof
03/12/2009US20090069310 Anti-inflammatory medicaments
03/12/2009US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor
03/12/2009US20090069303 Phthalazinone derivatives
03/12/2009US20090069277 Compounds and compositions for treating infection
03/12/2009US20090069259 Treatment of neuropathic pain with zinc finger proteins
03/12/2009US20090069225 Somatostatin analogues
03/12/2009US20090068737 Methods of inhibiting interleukin-17 receptor
03/12/2009US20090068720 Useful polypeptides
03/12/2009US20090068289 Formulation for menopausal women
03/12/2009US20090068265 Ecklonia cava extracts for alleviating or preventing asthmatic reactions
03/12/2009US20090068262 Rapid dissolution of combination products
03/12/2009US20090068198 Antibody and Uses Thereof
03/12/2009US20090068195 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
03/12/2009US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents
03/12/2009US20090068188 C-C chemokine receptor 3 proteins
03/12/2009US20090068180 treating rheumatoid arthritis or graft-versus-host disease, comprising administering a Sphingosine-1-phosphate lyase inhibitors such as 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime and at least one additional immunosuppressant and/or antiinflammatory agent
03/12/2009US20090068157 Derivation of unlimited quantities of neutrophils on monocyte/dendritic cells
03/12/2009US20090068150 Lactic acid bacteria culture of mung bean and the preparation method of the same, and the cosmetic composition comprising the same
03/12/2009US20090068143 Orally effective cannabinoid analogs
03/12/2009US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION
03/12/2009US20090068101 A1 Adenosine Receptor Antagonists
03/12/2009CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
03/12/2009CA2698173A1 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof
03/11/2009EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation
03/11/2009EP2033972A1 Screening method for candidate drugs
03/11/2009EP2033955A1 Urea derivatives of 1H-pyrazol-4-carboxylic acid with neutrophil chemotaxis inhibiting activity
03/11/2009EP2033953A1 Vanilloid receptor modulators
03/11/2009EP2033660A1 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion
03/11/2009EP2033659A2 Inhibitors of complement activation
03/11/2009EP2033658A1 Anitbodies to cytokines in the prevention and treatment of inflammatory bowel disease
03/11/2009EP2033648A2 Sustained release drug delivery system containing codrugs
03/11/2009EP2033646A1 Prophylactic and/or therapeutic agent for rheumatoid arthritis
03/11/2009EP2033644A1 Spiroindene and spiroindane compounds
03/11/2009EP2032748A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
03/11/2009EP2032573A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
03/11/2009EP2032555A1 Pyrrole derivatives with crth2 receptor modulator activity
03/11/2009EP2032543A1 2-anilino-4-aminoalkyleneaminopyrimidines
03/11/2009EP2032539A2 Benzazepinones as sodium channel blockers
03/11/2009EP2032170A1 Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
03/11/2009EP2032147A1 Cox-2 inhibitor
03/11/2009EP2032128A1 Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
03/11/2009EP1888027B1 Medicated product for local use based on natural materials
03/11/2009EP1590324B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb
03/11/2009EP1517919B1 Marked peptides having affinity for a phospholipid and uses
03/11/2009EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/11/2009EP1411899B1 Taste masking composition
03/11/2009EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
03/11/2009EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
03/11/2009EP1318801B1 Topical analgesic compositions containing aliphatic polyamines and methods of using same